
KineMed
closedBiotechnology company specializing in translational and personalized medicine.
Date | Investors | Amount | Round |
---|---|---|---|
investor | €0.0 | round | |
investor | €0.0 | round | |
N/A | €0.0 | round | |
N/A | €0.0 | round | |
N/A | €0.0 | round | |
N/A | €0.0 | round | |
N/A | €0.0 | round | |
N/A | $2.1m | Early VC | |
Total Funding | 000k |
Related Content
Established in 1987 by Clyde Pratt, Kinamed, Inc. operates as a specialized medical device company focused on designing, manufacturing, and marketing implantables and instruments for the orthopedic, neurosurgery, and cardiothoracic specialties. Headquartered in Camarillo, California, the company has grown from its initial founding to distributing its products in over 38 countries. Clyde Pratt's journey in the orthopedic sector began in 1973 and includes founding Techmedica Inc. in 1981, a company that pioneered the use of CT image data for creating patient-specific implants before it was acquired. In late 1993, Pratt, along with a group of investors, purchased Kinamed from Kyocera Corporation, subsequently developing a portfolio of highly differentiated, proprietary products. In March 2022, after 29 years as CEO, Clyde Pratt transitioned to the role of Chairman of the Board, appointing Dr. Vineet K. Sarin as the new President and CEO to lead the company's next phase of growth.
Kinamed's business model is centered on the development and sale of these specialized medical devices to hospitals and surgical centers, leveraging a global network of distributors. The company is a privately held entity and has not received external funding, growing organically through its sales, which were estimated to be around $14.8 million annually with a revenue per employee of approximately $251,000. This sustained growth is attributed to a focus on creating unique products that address specific clinical needs, a strategy that proved successful in navigating competitive international markets.
The company's product portfolio is segmented into three main areas: orthopedics, neurosurgery, and cardiothoracic surgery. A key orthopedic product is the SuperCable® Iso-Elastic™ Polymer Cerclage system, a polymer-based solution designed to overcome issues associated with traditional wire cables in bone fixation. Another notable product is the CarboJet® CO2 Bone Preparation System, which cleans and prepares bone surfaces to improve cement fixation during orthopedic procedures. For patients with isolated, end-stage patello-femoral disease, Kinamed offers the KineMatch® Patello-Femoral Replacement, a patient-matched unicompartmental joint replacement. In the realm of neurosurgery, the NeuroPro® Rigid Fixation System is provided for cranial bone repair. The company also has offerings in surgical navigation with its NaviPro® systems for hip, knee, and shoulder procedures.
Keywords: medical devices, orthopedics, neurosurgery, surgical instruments, implantables, Clyde Pratt, CarboJet, SuperCable, KineMatch, cardiothoracic surgery, patient-matched implants, bone preparation system, polymer cerclage, cranial fixation, surgical navigation, patello-femoral replacement, joint replacement, medical technology, surgical implants, Kinamed Inc.